Alkem Laboratories Limited
NSE: ALKEMINE540L01014·HealthcareMidcap 150·www.alkemlabs.com ↗·Mcap ₹64,734 Cr·Listed 2015
₹5,274.00▼ ₹52.00  (−0.98%)
52W: ₹5,051 – ₹5,934 · Vol: 28.7K shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q4 FY18
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q1 FY20Q4 FY19Q3 FY19Q2 FY19Q4 FY18
Revenue from operations3,7403,6033,7374,0013,3713,1443,3743,4153,0322,9363,3243,4402,9682,9033,0413,0792,4842,6192,8002,7312,3182,3632,0032,0492,1822,2641,8501,8541,9251,9191,513
Other income1532001431041361469313412088.293.663.265.868.745.350.720.553.54246.796.435.543.527.527.931.417.527.79.42417.9
Total expenses3,1213,2463,0463,2092,7502,8932,7362,7692,5332,6442,7112,7982,6812,6572,5472,7282,2472,2092,2602,2221,8711,8511,5541,8411,8051,8861,6571,6831,6761,6171,450
EBITDA766517828921739391759753609402708747389353599454337498624593529600533303453453265235312364114
EBITDA margin20.5%14.4%22.2%23.0%21.9%12.4%22.5%22.0%20.1%13.7%21.3%21.7%13.1%12.2%19.7%14.7%13.6%19.0%22.3%21.7%22.8%25.4%26.6%14.8%20.8%20.0%14.3%12.7%16.2%19.0%7.5%
Finance costs46.653.942.13529.828.43628.129.126.925.530.329.82927.124.91710.61212.913.11817.114.21717.816.16.615.416.410.4
Depreciation1001069593.687.711285.378.980.583.469.673.972.478.378.477.483.177.572.870.56970.266.881.159.556.455.857.347.745.840.3
Profit before tax77242378189677139673178061936765564835321253940224346458255654354849323540541021019925832680.9
Tax25117112811610373.390.378.369.162.950.633.26514478.954.6134−69.42375.979.666.269.643.814.729.322.728.352.665.614.5
Net profit52125165377966832264170255030460461528867.746034810853355948046448242319239038118717120526066.3
Net margin13.9%7.0%17.5%19.5%19.8%10.3%19.0%20.6%18.1%10.4%18.2%17.9%9.7%2.3%15.1%11.3%4.4%20.4%19.9%17.6%20.0%20.4%21.1%9.3%17.9%16.8%10.1%9.2%10.7%13.6%4.4%
EPS (₹)43.4919.7753.1963.9955.5625.5752.3457.6045.6024.5549.7651.9023.985.9438.0327.679.0043.9645.5239.1537.7239.4835.3015.7931.9531.0215.5114.0016.9421.285.61
Net profit YoY−22.0%−22.1%+1.9%+11.0%+21.4%+5.9%+6.0%+14.2%+91.2%+349.9%+31.4%+76.8%–−37.5%−13.8%−37.7%–+15.0%+16.0%+13.5%+18.9%+26.5%+126.0%+12.3%+89.8%+46.1%–+157.0%–––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY20FY19FY18
Revenue from operations14,71212,96512,66811,59910,6348,3447,3576,431
Other income58349431121616310487.796
Total expenses12,25010,93110,83410,4088,9387,1896,4905,601
EBITDA3,0052,5122,2451,6092,0531,4731,1151,028
EBITDA margin20.4%19.4%17.7%13.9%19.3%17.7%15.2%16.0%
Finance costs16112211210752.465.154.655.3
Depreciation382357299310304253193143
Profit before tax2,8712,5272,0231,3051,8441,260955926
Tax518311212298164110181288
Net profit2,3512,2151,8111,0071,6801,149774638
Net margin16.0%17.1%14.3%8.7%15.8%13.8%10.5%9.9%
EPS (₹)192.51181.11150.1982.31137.6394.2663.6152.77
Net profit YoY+6.1%+22.3%+79.9%−40.1%–+48.6%+21.2%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow1,9631,9131,9481,6831,111
Investing cash flow−1,667−1,299−1,009113−1,435
Financing cash flow−503−811−1,145−1,761380
Capital expenditure617676259233339
Free cash flow (CFO − capex)1,3461,2371,6891,450772

Net profit trend

annual, ₹ crore
FY20
₹1,149
FY22
₹1,680+46%
FY23
₹1,007−40%
FY24
₹1,811+80%
FY25
₹2,215+22%
FY26
₹2,351+6%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated14 Aug 2026PDF on NSE XBRL
Q1 FY27Standalone14 Aug 2026PDF on NSE XBRL
Q4 FY26Consolidated28 May 2026PDF on NSE XBRL
Q4 FY26Standalone28 May 2026PDF on NSE XBRL
Q3 FY26Consolidated13 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone13 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated13 Nov 2025 PDF XBRL
Q2 FY26Standalone13 Nov 2025 PDF XBRL
Q1 FY26Consolidated12 Aug 2025 PDF XBRL
Q1 FY26Standalone12 Aug 2025 PDF XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)28.6×
P/B4.56×
ROEFY26, on average equity18.2%
Net margin16.0%
Debt / equity0.12×
Revenue CAGR (3Y)8.2%
Profit CAGR (3Y)32.7%
EPS (TTM)₹184.38
Market cap₹63,051 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
Balance sheet 31 Mar 2026
Total assets₹20,873 Cr+18%
Net worth₹13,820 Cr+15%
Total borrowings₹1,624 Cr+53%
Cash & bank balances₹248 Cr−18%
Investments₹1,869 Cr+1%
Inventories₹3,333 Cr+14%
Trade receivables₹2,979 Cr+21%
Trade payables₹2,244 Cr+22%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23Sept 23
Promoter49.7051.2051.2051.2053.0455.1355.6655.6656.3856.7456.7456.74
FII10.4210.169.979.489.119.4110.159.028.699.118.496.03
DII22.6321.4021.5421.9321.8019.4218.0119.2118.5715.6315.9117.64
of which MF16.7115.5716.0616.9416.67–––––––
Retail17.0417.0617.0917.1815.6915.7715.9015.8516.1518.3118.6019.36
Other public0.210.180.200.210.360.270.280.260.210.210.260.23
62,822 shareholders · NSE shareholding pattern filings.